Clearside's pipeline includes advanced and pre-clinical product candidates in diseases where macular edema is a common complication, including …



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *